We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Topical Finasteride in the Treatment of Idiopathic Hirsutism

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00564252
First Posted: November 27, 2007
Last Update Posted: November 27, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Firuzgar hospital affiliated to Iran University of Medical Sciences
Information provided by:
Iran University of Medical Sciences
  Purpose
the purpose of this study is to evaluate the efficacy of topical Finasteride in the treatment of idiopathic hirsutism

Condition Intervention
Idiopathic Hirsutism Drug: topical finasteride

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: The Efficacy of Topical Finasteride in the Treatment of Idiopathic Hirsutism

Resource links provided by NLM:


Further study details as provided by Iran University of Medical Sciences:

Primary Outcome Measures:
  • the efficacy of topical finasteride was determined by comparison of Ferriman-Gallwey score before and after medication [ Time Frame: 6 months ]

Secondary Outcome Measures:
  • the efficacy of topical finasteride was determined by comparison of mean hair thickness before and after medication [ Time Frame: 6 months ]

Enrollment: 56
Study Start Date: February 2006
Study Completion Date: October 2006
Intervention Details:
    Drug: topical finasteride
    0.2%topical(cream)finasteride twice a day for six months
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Idiopathic hirsutism which is defined as normal levels of androgens and normal ovulation
  • Normal serum prolactin

Exclusion Criteria:

  • Pregnancy
  • Simultaneous use of other drugs for the treatment of hirsutism
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00564252


Sponsors and Collaborators
Iran University of Medical Sciences
Firuzgar hospital affiliated to Iran University of Medical Sciences
Investigators
Study Director: iraj heydari, professor assistant endocrine and metabolism centre of Iran University of Medical Sciences
  More Information

ClinicalTrials.gov Identifier: NCT00564252     History of Changes
Other Study ID Numbers: 84-5-6886
IUMS127
First Submitted: November 26, 2007
First Posted: November 27, 2007
Last Update Posted: November 27, 2007
Last Verified: November 2007

Additional relevant MeSH terms:
Hirsutism
Hair Diseases
Skin Diseases
Virilism
Signs and Symptoms
Finasteride
5-alpha Reductase Inhibitors
Steroid Synthesis Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Urological Agents